Search by Drug Name or NDC
NDC 00173-0519-00 FLOLAN 1.5 mg/1 Details
FLOLAN 1.5 mg/1
FLOLAN is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GlaxoSmithKline LLC. The primary component is EPOPROSTENOL SODIUM.
MedlinePlus Drug Summary
Epoprostenol injection is used to treat certain kinds of pulmonary arterial hypertension (PAH; high blood pressure in the vessels carrying blood to the lungs, causing shortness of breath, dizziness, and tiredness). Epoprostenol may improve the ability to exercise and slow the worsening of symptoms in patients with PAH. Epoprostenol is in a class of medications called vasodilators and platelet-aggregation inhibitors. It works by relaxing the blood vessels, including those in the lungs, and improving blood flow.
Related Packages: 00173-0519-00Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Epoprostenol
Product Information
| NDC | 00173-0519 |
|---|---|
| Product ID | 0173-0519_8e8254ca-dbad-41f0-9c02-922425061a91 |
| Associated GPIs | 40170040102130 |
| GCN Sequence Number | 024472 |
| GCN Sequence Number Description | epoprostenol sodium (glycine) VIAL 1.5 MG INTRAVEN |
| HIC3 | B1C |
| HIC3 Description | PULMONARY ANTIHYPERTENSIVES, PROSTACYCLIN-TYPE |
| GCN | 56681 |
| HICL Sequence Number | 037760 |
| HICL Sequence Number Description | EPOPROSTENOL SODIUM (GLYCINE) |
| Brand/Generic | Brand |
| Proprietary Name | FLOLAN |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | epoprostenol sodium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 1.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | EPOPROSTENOL SODIUM |
| Labeler Name | GlaxoSmithKline LLC |
| Pharmaceutical Class | Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020444 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00173-0519-00 (00173051900)
| NDC Package Code | 0173-0519-00 |
|---|---|
| Billing NDC | 00173051900 |
| Package | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0173-0519-00) |
| Marketing Start Date | 1995-12-08 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |